The Dime: 11/20/2020

Following important cannabis news articles every day can be a real burn-out, we know. That’s why the Emerald rolls up a chronicle of the headiest news hits, and passes them to you at the end of each week. We Bring You: The Dime.

 

Written by Katie Bryan | Emerald Magazine

California’s Cannabiz Maze

Navigating the regulatory maze of California’s cannabis industry is a daunting task for craft growers and needlessly prohibits the sale of their cannabis directly to consumers.  According to Marijuana Business Daily, “[…] of the roughly 750 licensed farms in the county, about 20% had brands that could be accurately labeled as “estate grown.’” Small farms, like those located in the Emerald Triangle in Northern California, cannot bring their own brands to market as they lack the funds necessary to bypass the current distribution model, thereby constricting access to only the well-connected or well-financed operations.

In Hot Bong Water

The maker of Nerds candy — Ferrara Candy Co. — filed suit on Thursday, November 12th, in Los Angeles federal court against Tops Cannabis Co., according to Law360.com.  The suit alleges Tops Cannabis, a cannabis delivery company, has sold a Nerds parody product called “Medicated Nerds Rope,” constituting copyright infringement.

Plant by Numbers

A research team led by the University of Minnesota has validated a genetic test that can predict whether cannabis sativa plants will produce mostly CBD or THC molecules and have published their findings in the American Journal of Botany.  According to the University of Minnesota website: 

“Industrial hemp growers monitor Cannabis sativa plants throughout the season and send samples off for chemical analysis, but THC levels peak at the plant’s maturity and can catch growers off guard. If the crop exceeds federal THC levels, the growers must destroy the crop. This makes growing industrial hemp much riskier than other crops.”

Their research unearthed the discovery that, “CBDAS genotypes blindly predicted the THC:CBD ratio among clinical cultivars.”  These findings will be revolutionary for the industrialized hemp industry.

 

Emerald contributor since September 2020

Comments

Your email address will not be published.